Human melanoma/NG2 chondroitin sulfate proteoglycan is expressed in the sarcolemma of postnatal human skeletal myofibers: Abnormal expression in merosin-negative and Duchenne muscular dystrophies

Molecular and Cellular Neuroscience

Volumn 23, Issue 2, 2003, Pages 219-231

  Petrini, Stefania ^a   Tessa, Alessandra ^a   Carrozzo, Rosalba ^a   Verardo, Margherita ^a   Pierini, Roberta ^a   Rizza, Teresa ^a   Bertini, Enrico ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOMA CHONDROITIN SULFATE PROTEOGLYCAN; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; HUMAN CELL; MEROSIN NEGATIVE CONGENITAL MUSCULAR DYSTROPHY; MOUSE; MUSCULAR DYSTROPHY; MYOBLAST; MYOTUBE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PATHOGENESIS; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOLEMMA; SKELETAL MUSCLE;

MURINAE;

EID: 0038383042     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00033-2     Document Type: Article

References (55)

1. Alvarez K., Fadic R., Brandan E. Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy. J. Cell. Biochem. 85:2002;703-713.
2. Bowe M.A., Mendis D.B., Fallon J.R. The small leucine-rich repeat proteoglycan biglycan binds to α-dystroglycan and is upregulated in dystrophic muscle. J. Cell Biol. 148:2000;801-810.
3. Bumoi T.F., Reisfeld R.A. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc. Natl. Acad. Sci. USA. 79:1984;1245-1249.
4. Burg M.A., Tillet E., Timpl R., Stallcup W.B. Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules. J. Biol. Chem. 271:1996;26110-26116.
5. Caceres S., Cuellar C., Casar J.C., Garrido J., Schaefer L., Kresse H., Brandan E. Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle. Eur. J. Cell Biol. 79:2000;173-181.
6. Chen Y.-W., Zhao P., Borup R., Hoffman E.P. Expression profiling in the muscular dystrophies identification of novel aspects of molecular pathophysiology . J. Cell Biol. 151:2000;1321-1336.
7. Couvalt J., Sanes J. Distribution of N-CAM in synaptic and extrasynaptic portions of developing and adult skeletal muscle. J. Cell Biol. 102:1986;716-730.
8. Doane K.J., Howell S.J., Birk D.E. Identification and functional characterization of two type VI collagen receptors, alpha 3 beta 1 integrin and NG2, during avian corneal stromal development. Invest. Ophthalmol. Vis. Sci. 39:1998;263-275.
9. Donalies M., Cramer M., Ringwald M., Starzinski-Powitz A. Expression of M-cadherin, a member of the cadherin multigene family, correlates with differentiation of skeletal muscle cells. Proc. Natl. Acad. Sci. USA. 88:1991;8024-8028.
10. Fang X., Burg M.A., Barritt D., Dahlin-Huppe K., Nishiyama A., Stallcup W.B. Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. Mol. Biol. Cell. 10:1999;3373-3387.
11. Grako K.A., Stallcup W.B. Partecipation of the NG2 proteoglycan in rat aortic smooth muscle cells responses to platelet-derived growth factor. Exp. Cell Res. 221:1995;231-240.
12. Goretzki L., Burg M.A., Grako K.A., Stallcup W.B. High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J. Biol. Chem. 274:1999;16831-16837.
13. Helbling-Leclerc A., Zhang X., Topaloglu H., Cruaud C., Tesson F., Weissenbach J., Tomè F.M.S., Schwartz K., Fardeau M., Tryggvason K., Guicheny P. Mutations in the laminin a2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat. Genet. 11:1995;216-218.
14. Hillaire D., Leclerc A., Fauré S., Topaloglu H., Chiannilkulchai N., Guicheney P., Grinas L., Legos P., Philpot J., Evangelista T. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum. Mol. Genet. 3:1994;1657-1661.
15. Hodges B.L., Hayashi Y.K., Nonaka I., Wang W., Arahata K., Kaufman S.J. Altered expression of the α7β1 integrin in human and murine muscular dystrophies. J. Cell Sci. 110:1997;2873-2881.
16. Hoffman E.P., Brown R.H. Jr, Kunkel L.M. Dystrophin the protein product of the Duchenne muscular dystrophy locus . Cell. 51:1987;919-928.
17. Iida J., Meijne A.M., Spiro R.C., Roos E., Furcht L.T., McCarthy J.B. Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and alpha 4 beta 1 integrin. Cancer Res. 15:1995;2177-2185.
18. Iozzo R.V. Matrix proteoglycans from molecular design to cellular function. Annu. Rev. Biochem. 67:1998;609-652.
19. Jacobson C., Cote P., Rossi S., Rotundo R., Carbonetto S. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J. Cell Biol. 152:2001;435-450.
20. Knutson J.R., Iida J., Fields G.B., McCarthy J.B. CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol. Biol. Cell. 7:1996;383-396.
21. Leger O., Johnson-Leger C., Jackson E., Coles B., Dean C. The chondroitin sulfate proteoglycan NG2 is a tumor specific antigen on the chemically induced rat chondrosarcoma HSN. Int. J. Cancer. 58:1994;700-705.
22. Levine J.M., Nishiyama A. The NG2 chondroitin sulfate proteoglycan a multifunctional proteoglycan associated with immature cells . Perspect. Dev. Neurobiol. 3:1996;245-259.
23. Levine J.M., Stallcup W.B. Plasticity of developing cerebellar cells in vitro studied with antibodies against the NG2 antigen. J. Neurosci. 7:1987;2721-2731.
24. Lin X.H., Dahlin-Huppe K., Stallcup W.B. Interaction of the NG2 proteoglycan with the actin cytoskeleton. J. Cell Biochem. 63:1996;463-477.
25. Lin X.H., Grako K.A., Burg M.A., Stallcup W.B. NG2 proteoglycan and the actin-binding protein fascin define separate populations of actin-containing filopodia and lamellipodia during cell spreading and migration. Mol. Biol. Cell. 7:1996;1977-1993.
26. Man N.T., Ellis J., Love D., Davies K., Gatter K., Dickson G., Morris G. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of 19 monoclonal antibodies. Presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J. Cell Biol. 115:1991;1695-1700.
27. Martin S., Levine A.K., Chen Z.J., Ughrin Y., Levine J.M. Deposition of the NG2 proteoglycan at nodes of Ranvier in the peripheral nervous system. J. Neurosci. 21:2001;8119-8128.
28. Matsumura K., Campbell K.P. Dystrophin-glycoprotein complex its role in the molecular pathogenesis on muscular dystrophies . Muscle Nerve. 17:1994;2-15.
29. Midwood K.S., Salter D.M. Expression of NG2/human melanoma proteoglycan in human adult articular chondrocytes. Osteoarthritis Cartilagine. 6:1998;297-305.
30. Miranda A.F., Babiss L.E., Fisher P.B. Measurement of the effect of interferons on cellular differentiation of human skeletal muscle cells. Methods Enzymol. 119:1986;619-628.
31. Monaco A.P., Bertelson C.J., Liechti-Gallati S., Moser H., Kunkel L.M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 2:1988;90-95.
32. Mook-jung I., Gordon H. Acetylcholine receptor clustering in C2 muscle cells requires chondroitin sulfate. J. Neurobiol. 28:1995;482-492.
33. Moore S.E., Walsh F.S. Specific regulation of N-CAM/D2-CAM cell adhesion molecule during skeletal muscle development. EMBO J. 4:1985;623-630.
34. Nishiyama A., Dahlin K.J., Prince J.T., Johnstone S.R., Stallcup W.B. The primary structure of NG2, a novel membrane-spanning proteoglycan. J. Cell Biol. 114:1991;359-371.
35. Nishiyama A., Dahlin K.J., Stallcup W.B. The expression of the NG2 proteoglycan in the developing rat limb. Development. 111:1991;933-944.
36. Nishiyama A., Lin X.H., Giese N., Heldin C.H., Stallcup W.B. Colocalization of NG2 and PDGFα receptor on O2A progenitor cells in the developing rat brain. J. Neurosci. Res. 43:1996;299-314.
37. Nishiyama A., Lin X.H., Stallcup W.B. Generation of truncated forms of the NG2 proteoglycan by cell surface proteolysis. Mol. Biol. Cell. 6:1995;1819-1832.
38. Peng H., Xie H., Rossi S., Rotundo R. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J. Cell Biol. 145:1999;911-921.
39. Pluschke G., Vanek M., Evans A., Dittmar T., Schmid P., Itin P., Filardo E., Reisfeld R. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc. Natl. Acad. Sci. USA. 93:1996;9710-9715.
40. Pouly S., Prat A., Blain M., Olivier A., Antel J. NG2 immunoreactivity on human brain endothelial cells. Acta Neuropathol. 102:2001;313-320.
41. Real F.X., Houghton A.N., Albino A.P., Cordon-Cardo C., Melamed M.R., Oettgen H.F., Old L.J. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies specificity analysis and comparison of antigen expression in cultured cells and tissues . Cancer Res. 45:1985;4401-4411.
42. Schrappe M., Klier F.G., Spiro R.C., Waltz T.A., Reisfeld R.A., Gladson C.L. Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells. Cancer Res. 51:1991;4986-4993.
43. Sewry C., Philpot J., Mahony D., Wilson L.A., Muntoni F., Dubowitz V. Expression of laminin subunits in congenital muscular dystrophy. Neuromusc. Disord. 5:1995;307-316.
44. Sewry C.A., Philpot J., Sorokin L.M., Wilson L.A., Naom I., Goodwin F., D'Alessandro M., Dubowitz V., Muntoni F. Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy. Lancet. 2:1996;582-584.
45. Smith F.O., Rauch C., Williams D.E., March C.J., Arthur D., Hilden J., Lampkin B.C., Buckley J.D., Buckley C.V., Woods W.G., Dinndorf P.A., Sorensen P., Kersey J., Hammond D., Bernstein I.D. The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells, but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23. Blood. 87:1996;1123-1133.
46. Stallcup, W.B. 2003. The NG2 proteoglycan: past insights and future prospects. J. Neurocytol. (In press).
47. Stallcup W.B., Beasley L. Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan. J. Neurosci. 7:1987;2737-2744.
48. Stallcup W.B., Beasley L., Levine J. Cell-surface molecules that characterize different stages in the development of cerebellar interneurons. Cold Spring Harb. Symp. Quant. Biol. 48:1983;761-774.
49. Stallcup W.B., Dahlin K., Healy P. Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen. J. Cell Biol. 111:1990;3177-3188.
50. Sunada Y., Campbell K.P. Dystrophin-glycoprotein complex molecular organization and critical roles in skeletal muscle . Curr. Opin. Neurol. 8:1995;379-384.
51. Tillet E., Ruggiero F., Nishiyama A., Stallcup W.B. The membrane-spanning proteoglycan NG2 binds to collagen V and VI through the central nonglobular domain of its core protein. J. Biol. Chem. 272:1997;10769-10776.
52. Tomè F.M.S., Evangelista T., Leclerc A., Sunada Y., Manole E., Estournet B., Barois A., Campbell K.P., Fardeau M. Congenital muscular dystrophy with merosin deficiency. Crit. Rev. Acad. Sci. III. 317:1994;351-357.
53. Vachon P.H., Xu H., Liu L., Loechel F., Hayashi Y., Arahata K., Reed J.C., Wever U.M., Engvall E. Integrins (α7β1) in muscle function and survival. J. Clin. Invest. 100:1997;1870-1881.
54. Vainzof M., Marie S.K., Reed U.C., Schwartzman J.S., Pavanello R.C., Passos-Bueno M.R., Zatz M. Deficiency of merosin (laminin M or alpha2) in congenital muscular dystrophy associated with cerebral white matter alterations. Neuropediatrics. 26:1995;293-297.
55. Wilson S.-S., Baetge E.E., Stallcup W.B. Antisera specific for cell lines with mixed neuronal and glial properties. Dev. Biol. 83:1981;146-153.